PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Scientists uncover new target for brain cancer treatment

2014-01-09
(Press-News.org) Contact information: John Wallace
wallacej@vcu.edu
804-628-1550
Virginia Commonwealth University
Scientists uncover new target for brain cancer treatment

A new study is giving researchers hope that novel targeted therapies can be developed for glioblastoma multiforme (GBM), the most common and most aggressive form of brain cancer, after demonstrating for the first time that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) is a driving force behind the disease's aggressive and invasive nature.

Recently published in the journal Neuro-Oncology, the study led by Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine (VIMM) researchers used cell cultures and animal models to uncover the mechanisms by which mda-9/syntenin causes GBM to grow and invade normal brain tissue. Additionally, by using publicly available cancer genomic database information (bioinformatics) and analyzing tissue samples from patients with GBM, the researchers found that increased levels of mda-9/syntenin correlated with more advanced tumors and shorter survival. The study's discoveries pinpoint molecular targets that could be used to develop new therapies, and also suggest that the gene could be used to help stage and monitor this aggressive disease.

"Our current study represents a major breakthrough in understanding what drives GBM, and it is a starting point for the development of future therapies," says the study's lead author Paul B. Fisher, M.Ph., Ph.D., Thelma Newmeyer Corman Endowed Chair in Cancer Research and co-leader of the Cancer Molecular Genetics research program at VCU Massey Cancer Center, chairman of the Department of Human and Molecular Genetics at VCU School of Medicine and director of the VIMM. "Because mda-9/syntenin is expressed more in advanced disease, we are also hopeful that we may be able to use the gene to monitor for disease progression and test whether certain therapies are working."

Mda-9/syntenin was originally discovered by Fisher, and through bioinformatics he has found that the gene is overexpressed in a majority of cancers. He and his colleagues also found that mda-9/syntenin interacts with a predicted 151 cancer-related proteins through its PDZ domains, which are chains of amino acids that enable cell signaling by facilitating interactions between proteins.

In GBM, Fisher and his colleagues demonstrated that overexpression of mda-9/syntenin enhanced the cells' ability to invade healthy tissue. In contrast, blocking expression of mda-9/syntenin in animal models reduced invasion, suppressed cell migration and caused tumors to shrink. Additionally, blocking the expression of mda-9/syntenin decreased the production and secretion of interleukin 8 (IL-8) proteins, which are signaling proteins that contribute to tumor growth and progression by promoting cell migration and the development of new blood vessels, a process known as angiogenesis.

"We are now focusing on developing small molecules, or drugs, that block the binding of specific cancer-promoting proteins that interact with mda-9/syntenin through its PDZ domains," says Fisher. "If successful, these PDZ-targeted therapies could potentially lead to effective treatments for GBM."



INFORMATION:

Fisher collaborated on this research with Timothy P. Kegelman, graduate student in the M.D./Ph.D. program at VCU School of Medicine; Manny Bacolod, Ph.D., instructor in the Department of Human and Molecular Genetics at VCU School of Medicine; Bin Hu, Ph.D., postdoctoral researcher in the VCU Department of Human and Molecular Genetics; Devanand Sarkar, M.B.B.S., Ph.D., Harrison Research Scholar and member of the Cancer Molecular Genetics research program at VCU Massey, associate professor in the VCU Department of Human and Molecular Genetics and associate scientific director of cancer therapeutics at VIMM; Swadesh K. Das, Ph.D., instructor in the VCU Department of Human and Molecular Genetics and VIMM member; Luni Emdad, M.B.B.S., Ph.D., member of the Cancer Molecular Genetics research program at VCU Massey, assistant professor in the VCU Department of Human and Molecular Genetics and VIMM member; Santanu Dasgupta, Ph.D., member of the Cancer Molecular Genetics research program at VCU Massey, assistant professor in the VCU Department of Human and Molecular Genetics and VIMM member; Mitchell E. Menezes, Ph.D., postdoctoral research scientist in the VCU Department of Human and Molecular Genetics; Christine E. Fuller, M.D., professor and director of neuropathology in the Department of Pathology at VCU School of Medicine; Paul Dent, Ph.D., Universal Corporation Distinguished Professor for Cancer Cell Signaling and member of the Developmental Therapeutics research program at VCU Massey and professor and chair of research in the Department of Neurosurgery at VCU School of Medicine; Albert S. Baldwin, Ph.D., professor at the University of North Carolina; Jeffrey N. Bruce, M.D., professor and vice-chair at Columbia University; and Maurizio Pellecchia, Ph.D., professor at Sanford-Burnham Medical Research Institute.

This study was supported by National Institutes of Health grant R01 CA134721, the National Foundation for Cancer Research, Goldhirsh Foundation for Brain Tumor Research, the Dana Foundation and, in part, by VCU Massey Cancer Center's NIH-NCI Cancer Center Support Grant P30 CA016059.

The full manuscript of this study is available online at: http://neuro-oncology.oxfordjournals.org/content/early/2013/12/03/neuonc.not157.full?keytype=ref&ijkey=7bky3mv0fplTyPb

News directors: Broadcast access to VCU Massey Cancer Center experts is available through VideoLink ReadyCam. ReadyCam transmits video and audio via fiber optics through a system that is routed to your newsroom. To schedule a live or taped interview, contact John Wallace, (804) 628-1550.

About VCU Massey Cancer Center

VCU Massey Cancer Center is one of only 68 National Cancer Institute-designated institutions in the country that leads and shapes America's cancer research efforts. Working with all kinds of cancers, the Center conducts basic, translational and clinical cancer research, provides state-of-the-art treatments and clinical trials, and promotes cancer prevention and education. Since 1974, Massey has served as an internationally recognized center of excellence. It offers the most cancer clinical trials in Virginia and serves patients at 10 locations. Its 1,000 researchers, clinicians and staff members are dedicated to improving the quality of human life by developing and delivering effective means to prevent, control and ultimately to cure cancer. Visit Massey online at http://www.massey.vcu.edu or call 877-4-MASSEY for more information.

About VCU and the VCU Medical Center

Virginia Commonwealth University is a major, urban public research university with national and international rankings in sponsored research. Located in downtown Richmond, VCU enrolls more than 31,000 students in 222 degree and certificate programs in the arts, sciences and humanities. Sixty-six of the programs are unique in Virginia, many of them crossing the disciplines of VCU's 13 schools and one college. MCV Hospitals and the health sciences schools of Virginia Commonwealth University compose the VCU Medical Center, one of the nation's leading academic medical centers. For more, see http://www.vcu.edu.



ELSE PRESS RELEASES FROM THIS DATE:

Remission from depression much slower in adults who were abused in childhood

2014-01-09
Remission from depression much slower in adults who were abused in childhood TORONTO, ON – Remission from depression is delayed in adults who have experienced childhood physical abuse or parental addictions, a new study by University of Toronto researchers has found. ...

Improved regulations to protect human research subjects would reduce burden on IRBs while better protecting study participants

2014-01-09
Improved regulations to protect human research subjects would reduce burden on IRBs while better protecting study participants WASHINGTON – Proposed updates to federal regulations that protect human research subjects need additional clarification when applied to the ...

Minimalistic raiding parties of a slave-hunting ant crack castles

2014-01-09
Minimalistic raiding parties of a slave-hunting ant crack castles A group of scientists from the University of Mainz and the Senckenberg Museum of Natural History Goerlitz, headed by Susanne Foitzik and Bernhard Seifert, recently described a new slave-making ant ...

Researchers find comparable long-term outcomes between diastolic and systolic heart failure patients

2014-01-09
Researchers find comparable long-term outcomes between diastolic and systolic heart failure patients (Boston) – A new study by researchers at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) found comparable long-term outcomes ...

Genetic testing to produce more offspring

2014-01-09
Genetic testing to produce more offspring Scientists discover cause of infertility in cattle The Fleckvieh is a breed of cattle that originated in the Alpine region. A robust animal, it is now found on every continent, with an estimated worldwide ...

Minorities and poor have more advanced thyroid cancers when diagnosed, UCLA study shows

2014-01-09
Minorities and poor have more advanced thyroid cancers when diagnosed, UCLA study shows Black patients fare worst; Asians, Hispanics survive longest with disease UCLA researchers have found that minority patients and those ...

Novel potential approach to prevent infection in patients with liver failure

2014-01-09
Novel potential approach to prevent infection in patients with liver failure Findings published in the American Association for the Study of Liver Diseases journal, Hepatology, indicate that infection, the commonest cause of mortality in patients with acute liver failure (ALF), ...

Fusion instabilities lessened by unexpected effect

2014-01-09
Fusion instabilities lessened by unexpected effect Control of widely recognized distortion may allow greater output at Sandia's Z machine ALBUQUERQUE, N.M. — A surprising effect created by a 19th century device called a Helmholz coil offers clues about how ...

Big data: A method for obtaining large, phylogenomic data sets

2014-01-09
Big data: A method for obtaining large, phylogenomic data sets New approach combines long-range PCR and next-generation sequencing, allowing systematists to sequence large portions of the genome Traditional molecular systematic studies have progressed by sequencing genes one by ...

SHY hypothesis explains that sleep is the price we pay for learning

2014-01-09
SHY hypothesis explains that sleep is the price we pay for learning MADISON — Why do animals ranging from fruit flies to humans all need to sleep? After all, sleep disconnects them from their environment, puts them at risk and keeps them from seeking ...

LAST 30 PRESS RELEASES:

Children fast from clear liquids much longer before surgery than guidelines recommend, large study shows

Food insecurity, loneliness can increase the risk of developing chronic pain after surgery

Cesarean delivery linked to higher risk of pain and sleep problems after childbirth

New global burden of disease study: Mortality declines, youth deaths rise, widening health inequities

Chemobiological platform enables renewable conversion of sugars into core aromatic hydrocarbons of petroleum

Individualized perioperative blood pressure management in patients undergoing major abdominal surgery

Proactive vs reactive treatment of hypotension during surgery

Different types of depression linked to different cardiometabolic diseases

Ketogenic diet may protect against stress experienced in the womb

Adults 65 years and older not immune to the opioid epidemic, new study finds

Artificial intelligence emerging as powerful patient safety tool in pediatric anesthesia

Mother’s ZIP code, lack of access to prenatal care can negatively impact baby’s health at birth, new studies show

American Society of Anesthesiologists honors John M. Zerwas, M.D., FASA, with Distinguished Service Award

A centimeter-scale quadruped piezoelectric robot with high integration and strong robustness

Study confirms that people with ADHD can be more creative. The reason may be that they let their mind wander

Research gives insight into effect of neurodegenerative diseases on speech rhythm

Biochar and plants join forces to clean up polluted soils and boost ecosystem recovery

Salk scientist Joseph Ecker awarded McClintock Prize for Plant Genetics and Genome Studies

ADHD: Women are diagnosed five years later than men, despite symptoms appearing at the same age.

Power plants may emit more pollution during government shutdowns

Increasing pressures for conformity de-skilling and demotivating teachers, study warns

Researchers develop smarter menstrual product with potential for wearable health monitoring

Microwaves for energy-efficient chemical reactions

MXene current collectors could reduce size, improve recyclability of Li-ion batteries

Living near toxic sites linked to aggressive breast cancer

New discovery could open door to male birth control

Wirth elected Fellow of American Physical Society

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: October 10, 2025

Destined to melt

Attitudes, not income, drive energy savings at home

[Press-News.org] Scientists uncover new target for brain cancer treatment